Skip to main content
Log in

Pharmacokinetics of ritodrine diastereomers in patients pregnant with singletons and twins

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

The chiral pharmacokinetics and pharmacodynamics of ritodrine in patients pregnant with singletons and twins were investigated to determine the optimal use of ritodrine.

Methods

Eight and 20 patients with threatened preterm delivery of singletons and twins, respectively, were infused with ritodrine diastereomers. Serum concentrations of the drug were then measured using a newly developed method of chiral high-performance liquid chromatography.

Results

Almost double the dosage of racemic ritodrine was required to prolong pregnancies with twins compared with those of singletons (2.20 ± 1.06 vs. 1.24 ± 0.36 μg/min per kilogram; p < 0.0001). The mean ratios of (–)-ritodrine to (+)-ritodrine in singleton and twin pregnancies were 1.17 ± 0.10 and 1.16 ± 0.10, respectively. However, the serum concentration and dosage ratio (C/D ratio) of (−)-ritodrine as significantly higher than that of (+)-ritodrine (p < 0.0001), whereas the clearance of (−)-ritodrine was significantly lower than that of (+)-ritodrine (p < 0.0001). A comparison of the gestation period (weeks) and diastereomer clearance did not reveal significant regression in the total analysis of the data obtained from singleton and twin pregnancies.

Conclusion

These results indicate that the clinical effectiveness of ritodrine diastereomers should be evaluated and that administration guidelines should be established based upon serum concentrations so that ritodrine can be more effectively administered to pregnant patients carrying either singletons or twins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Caritis SN (1988) A pharmacologic approach to the infusion of ritodrine. Am J Obstet Gynecol 158:380–384

    PubMed  CAS  Google Scholar 

  2. Kuhnert BR, Gross TL, Kuhnert PM, Erhard P, Brashar WT (1986) Ritodrine pharmacokinetics. Clin Pharmacol Ther 40:656–664

    PubMed  CAS  Google Scholar 

  3. Caritis SN, Lin LS, Wong LK (1985) Evaluation of the pharmacodynamics and pharmacokinetics of ritodrine when administered as a loading dose. On establishing a potentially useful drug administration regimen in cases of fetal distress. Am J Obstet Gynecol 152:1026–1031

    PubMed  CAS  Google Scholar 

  4. Caritis SN, Venkataramanan R, Darby MJ, Chiao JP, Krew M (1990) Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen. Am J Obstet Gynecol 162:429–437

    PubMed  CAS  Google Scholar 

  5. Neri I, Monari F, Valensise H, Vasapollo B, Facchinetti F, Volpe A (2008) Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between atosiban and ritodrine. Am J Perinatol 26(4):259–263

    Google Scholar 

  6. Chan TF, Chung YF, Chen HS, Su JH, Yuan SS (2004) Elevated amniotic fluid leptin levels in early second trimester are associated with earlier delivery and lower birthweight in twin pregnancy. Acta Obstet Gynecol Scand 83:707–710

    Article  PubMed  Google Scholar 

  7. Norwitz ER, Edusa V, Park JS (2005) Maternal physiology and complications of multiple pregnancy. Semin Perinatol 29:338–348

    Article  PubMed  Google Scholar 

  8. Caritis SN, Lin LS, Toig G, Wong LK (1983) Pharmacodynamics of ritodrine in pregnant women during preterm labor. Am J Obstet Gynecol 147:752–759

    PubMed  CAS  Google Scholar 

  9. Konda A, Nodai A, Soma M, Koga Y, Yoshida H, Toda T, Hayakawa T, Inotsume N (2008) Ritodrine pharmacokinetics in twin pregnancy patients. Eur J Clin Pharmacol 64:399–404

    Article  PubMed  CAS  Google Scholar 

  10. Yamasaki N, Fukuda Y, Shibazaki Y, Niizato T, Kosugi I, and Yoshioka S (1995) (-)-ritodrine, therapeutic compositions and use, and method of preparation. US Patent 5449694.

  11. O’Reilly RA (1974) Interaction of sodium warfarin and rifampin. Studies in man. Ann Intern Med 81:337–340

    Google Scholar 

  12. Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K, Furukawa M (1986) Synthesis and antibacterial activities of optically active of loxacin. Antimicrob Agents Chemother 29:163–164

    PubMed  CAS  Google Scholar 

  13. Narimatsu S, Gotoh M, Masubuchi Y, Horie T, Ohmori S, Kitada M, Kageyama T, Asaoka K (1996) Yamamoto I, Suzuki T. Stereoselectivity in bunitrolol 4-hydroxylation in liver microsomes from marmosets and Japanese monkeys. Biol Pharm Bull 119:1429–1433

    Google Scholar 

  14. Konda A, Soma M, Ito T, Koga Y, Yakeuchi Y, Toda T, Hayakawa T, Inotsume N (2009) Stereoselective analysis of ritodrine diastereomers in human serum using high performance liquid chromatography. (in press)

  15. Campbell DM (1986) Maternal adaptation in twin pregnancy. Semin Perinatol 10:14–18

    PubMed  CAS  Google Scholar 

  16. Clinical Management Guidelines for Obstetrician-Gynecologists (2004) Multiple gestation: Complicated twin, triplet, and higher-order multiple pregnancy. Obstet Gynecol 104:869–883

    Google Scholar 

  17. Allegaert K, van Mieghem T, Verbesselt R, de Hoon J, Rayyan M, Devlieger R, Deprest J, Anderson BJ (2008) Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol 200(2):170.e1–7

    Google Scholar 

  18. Buchanan ML, Easterling TR, Carr DB, Shen DD, Risler LJ, Nelson WL, Mattison DR, Hebert MF (2008) Clonidine pharmacokinetics in pregnancy. Drug Metab Dispos 37(4):702–705

    Google Scholar 

  19. Pacheco LD, Ghulmiyyah LM, Snodgrass WR, Hankins GD (2007) Pharmacokinetics of corticosteroids during pregnancy. Am J Perinatol 24:79–82

    Article  PubMed  Google Scholar 

  20. Ballabh P, Lo ES, Cooper KJ, TB ZI, Auld PAM, Krauss AN (2002) Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 71:39–45

    Article  PubMed  CAS  Google Scholar 

  21. Swamy GK, Ostbye T, Skjaerven R (2008) Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 299:1429–1436

    Article  PubMed  CAS  Google Scholar 

  22. Alvarez M, Pita S, Costas E, Cupeiro A, Chaves OF, García M, Sola A, Goyanes V (1995) Long term effects of ritodrine on blood pressure and heart rate of adolescents exposed during the prenatal stage. Eur J Obstet Gynecol Reprod Biol 59:137–141

    Article  PubMed  CAS  Google Scholar 

  23. Kurtoglu S, Akcakus M, Keskin M, Ozcan A, Hussain K (2005) Severe hyperinsulinaemic hypoglycaemia in a baby born to a mother taking oral ritodrine therapy for premature labour. Horm Res 64:61–63

    Article  PubMed  CAS  Google Scholar 

  24. Okumus N, Turkyilmaz C, Onal EE, Atalay Y, Koç E, Nas T (2004) Ritodrine-induced transient neutropenia in newborn twins after in uterus exposure: report of first cases. Br J Clin Pharmacol 58:445–446

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Inotsume.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konda, A., Ito, T., Yoshida, H. et al. Pharmacokinetics of ritodrine diastereomers in patients pregnant with singletons and twins. Eur J Clin Pharmacol 65, 913–917 (2009). https://doi.org/10.1007/s00228-009-0665-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-009-0665-0

Keywords

Navigation